Acrux Limited
Australian pharmaceutical firm initiates IPO
Published in Medical Device Business Week, September 29th, 2004
The IPO is underwritten by Goldman Sachs JBWere and Wilson HTM, with Goldman Sachs JBWere acting as lead manager to the offer and Wilson HTM and ABN Amro Morgans serving as co-lead managers.
In addition to the fully underwritten issue of 30 million new shares, up to 8.3 million existing shares may be made available for general public applications. On completion of the offer, Acrux will have a market capitalization of $130.9 million.
The AUD $30 million raised from the sale of new shares will be used by Acrux...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Accredo Health, Inc.
Pharmaceutical firm reports 15% increase in income - Achillion Pharmaceuticals, Inc.
New CEO named at pharmaceutical firm - Agenix Limited
Biotech firm reaches significant operational milestones, cleans up balance sheet - Applied DNA Sciences, Inc.
Biotech company engages investment advisory services firm - Ark Therapeutics Group plc
Marketing deal signed with Teva Medical for Kerraboot in Israel - Australian Cancer Technology
Cancer drug maker provides corporate update - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
